Karen Wilde knows from her own perspective how important it is to that Myeloma Australia receives financial support and that's why she's thrilled that the racing industry will again be to the fore ...
New research could transform how broken bones are treated, with the development of a special zinc-based dissolvable material that could replace the metal plates and screws typically used to hold ...
Zach Stubbings was diagnosed with multiple myeloma, cancer of the blood and bone marrow, in 2013, thirteen years after ...
During a Case-Based Roundtable® event, Muhammad Umair Mushtaq, MD, discussed managing long-term toxicity concerns related to ...
A research team from the Heidelberg Medical Faculty, the German Cancer Research Center (DKFZ), the Berlin Institute of Health ...
Researchers sought to determine whether teclistamab would lead to a clinical response in patients with relapsed/refractory multiple myeloma.
2d
Acceptance follows resolution of third-party fill/finish manufacturing issuesFDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, ...
Researchers discover that bone marrow cancer cells diversify drastically when exiting the bone marrow, which also affects the ...
When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...
When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...
Only a matching bone marrow donor will extend the life of Peter McCleave as there is no known cure for the blood cancer ...
The phase 2 REST trial by Frida Bugge Askeland and colleagues, reported in The Lancet Haematology, provides insight into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback